Browsing Awaiting Allocation by Author "Edan, G"
Now showing items 1-1 of 1
-
Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β.
Simpson-Yap, S; Pirmani, A; De Brouwer, E; Peeters, LM; Geys, L; Parciak, T; Helme, A; Hillert, J; Moreau, Y; Edan, G (2022-10)BACKGROUND: Interferon-β, a disease-modifying therapy (DMT) for MS, may be associated with less severe COVID-19 in people with MS. RESULTS: Among 5,568 patients (83.4% confirmed COVID-19), interferon-treated patients had ...